Guy G E, Shetty P C, Sharma R P, Burke M W, Burke T H
Department of Diagnostic Radiology, Henry Ford Hospital, Detroit, MI 48202.
AJR Am J Roentgenol. 1992 Sep;159(3):521-6. doi: 10.2214/ajr.159.3.1503016.
The major risk of transcatheter embolotherapy for acute hemorrhage in the lower gastrointestinal tract is irreversible intestinal ischemia. The authors studied the efficacy and safety of superselective transcatheter embolization with polyvinyl alcohol particles in arresting acute hemorrhage in the lower gastrointestinal tract.
All patients with clinical or scintigraphic evidence of acute hemorrhage in the lower gastrointestinal tract were considered for superselective embolization. The nine patients with angiograms that showed active hemorrhage in the lower gastrointestinal tract underwent the procedure. Superselective embolization was done through a 3-French catheter and was accomplished by using 100- to 590-microns polyvinyl alcohol particles. The segments of the intestinal tracts involved in the embolizations were examined for the presence of ischemia by endoscopy (n = 7) or histologic evaluation of a surgical specimen (n = 2) 2-44 days (mean, 11 days) after embolization or by clinical evaluation (n = 1).
The lesions treated by this method were located in the colon (n = 8) and jejunum (n = 1). Immediate hemostasis was achieved in every case. Three patients had recurrent lower gastrointestinal hemorrhage 1-24 days (mean, 9 days) after initial embolization. Two of these patients had surgery, while one had a successful second embolization. Two asymptomatic patients were found endoscopically to have small areas of ischemia involving only the mucosa. Only one patient was shown to have severe mucosal ischemia; this involved the colon in a distribution that suggested it was not caused by the embolization.
Ten superselective embolization procedures that used polyvinyl alcohol particles successfully controlled hemorrhage in the lower gastrointestinal tract in nine patients. In no case was intestinal infarction induced by the procedure, and only two endoscopically proved cases of asymptomatic mucosal ischemia occurred.
经导管栓塞疗法治疗下消化道急性出血的主要风险是不可逆性肠缺血。作者研究了使用聚乙烯醇颗粒进行超选择性经导管栓塞术治疗下消化道急性出血的疗效和安全性。
所有有临床或闪烁扫描证据表明存在下消化道急性出血的患者均考虑行超选择性栓塞术。9例血管造影显示下消化道有活动性出血的患者接受了该手术。通过3法国导管进行超选择性栓塞,使用100至59μm的聚乙烯醇颗粒完成栓塞。栓塞术后2至44天(平均11天),通过内镜检查(n = 7)或手术标本的组织学评估(n = 2)或临床评估(n = 1)检查栓塞所涉及的肠道段是否存在缺血。
用该方法治疗的病变位于结肠(n = 8)和空肠(n = 1)。每例均实现了即时止血。3例患者在初次栓塞后1至24天(平均9天)出现下消化道再次出血。其中2例患者接受了手术,1例患者第二次栓塞成功。2例无症状患者经内镜检查发现有仅累及黏膜的小面积缺血区域。仅1例患者显示有严重的黏膜缺血;这累及结肠,其分布提示并非由栓塞所致。
10例使用聚乙烯醇颗粒的超选择性栓塞术成功控制了9例患者的下消化道出血。该手术未引起肠梗死,仅发生2例经内镜证实的无症状黏膜缺血病例。